A professional’s guide to end of life care in motor neurone disease (MND)
1QrDn0Q
1QrDn0Q
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Medications at <strong>end</strong> <strong>of</strong> <strong>life</strong><br />
If someone is dy<strong>in</strong>g, early <strong>in</strong>tervention can prevent symp<strong>to</strong>ms from<br />
becom<strong>in</strong>g distress<strong>in</strong>g. As people are dy<strong>in</strong>g, they will become more<br />
drowsy as part <strong>of</strong> the dy<strong>in</strong>g process. Occasionally, the doses <strong>of</strong><br />
medication required for symp<strong>to</strong>m control may contribute <strong>to</strong> drows<strong>in</strong>ess.<br />
Only medication <strong>to</strong> control or prevent symp<strong>to</strong>ms is appropriate<br />
at this time. Thought should be given <strong>to</strong> s<strong>to</strong>pp<strong>in</strong>g medication not<br />
specifically aimed at this purpose. 6<br />
The GP, specialist or other appropriate prescriber will consider<br />
anticipa<strong>to</strong>ry prescrib<strong>in</strong>g <strong>of</strong> a range <strong>of</strong> medications <strong>to</strong> address<br />
worsen<strong>in</strong>g symp<strong>to</strong>ms, <strong>in</strong>clud<strong>in</strong>g:<br />
• antimuscar<strong>in</strong>ics, such as hyosc<strong>in</strong>e hydrobromide and glycopyrronium<br />
bromide, <strong>to</strong> reduce saliva and respira<strong>to</strong>ry secretions 6<br />
• medications <strong>to</strong> reduce anxiety/term<strong>in</strong>al restlessness, such as<br />
24, 25<br />
midazolam, haloperidol or levomepromaz<strong>in</strong>e.<br />
• opioid analgesics, such as morph<strong>in</strong>e sulphate or diamorph<strong>in</strong>e,<br />
<strong>to</strong> reduce cough reflex, relieve dyspnoea (breathlessness), fear<br />
and anxiety. They can also control pa<strong>in</strong> 26<br />
• antiemetics, such as levomepromaz<strong>in</strong>e or cycliz<strong>in</strong>e, for nausea 6<br />
Supplementary oxygen therapy is generally not very helpful for people<br />
with <strong>MND</strong>. It corrects oxygen saturations, but it is a ris<strong>in</strong>g level <strong>of</strong><br />
carbon dioxide that can lead <strong>to</strong> symp<strong>to</strong>ms and ultimately death <strong>in</strong><br />
people with <strong>MND</strong>. 21 However, oxygen may be used at <strong>end</strong> <strong>of</strong> <strong>life</strong> <strong>in</strong><br />
comb<strong>in</strong>ation with opiates and benzodiazep<strong>in</strong>es <strong>to</strong> reduce the distress<br />
<strong>of</strong> breathlessness. 27 The <strong>in</strong>volvement <strong>of</strong> a specialist palliative <strong>care</strong> team<br />
can ensure symp<strong>to</strong>m control and support for the person with <strong>MND</strong>.<br />
Pa<strong>in</strong><br />
People with <strong>MND</strong> rarely die a pa<strong>in</strong>ful death, although some people<br />
with <strong>MND</strong> do have pa<strong>in</strong> from musculoskeletal causes, such as<br />
muscle spasm, or from sk<strong>in</strong> pressure due <strong>to</strong> immobility. 26<br />
As they reach the term<strong>in</strong>al stage <strong>of</strong> <strong>MND</strong>, many people compla<strong>in</strong> <strong>of</strong><br />
generalised pa<strong>in</strong> and severe discomfort. This can <strong>of</strong>ten be treated<br />
with pa<strong>in</strong>killers. Carefully titrated opioid analgesics may be necessary,<br />
26, 28<br />
especially for pressure pa<strong>in</strong>, and should not be withheld if needed.<br />
Car<strong>in</strong>g for a person with <strong>MND</strong> at <strong>end</strong> <strong>of</strong> <strong>life</strong><br />
21